cystic fibrosis. Cystic fibrosis
Conditions
Interventions
Intervention 1: Intervention group: Patients in the intervention group received 4 cc of 7% hypertonic saline plus nebulizer, manufactured by Samen Pharmaceutical Company, every 12 hours for three mont
Sponsors
Mashhad University of Medical Sciences
Eligibility
Sex/Gender
All
Age
6 Years to 14 Years
Inclusion criteria
Inclusion criteria: Have cystic fibrosis ability to expectorate sputum The patient is in stable condition Pseudomonas sputum culture The forced expiratory volume in the first second is greater than 50%.
Exclusion criteria
Exclusion criteria: Hyperreactive pulmonary disease Oxygen saturation less than 94% in room air or with supplemental oxygen Use of intravenous antibiotics during the previous four weeks Change in cystic fibrosis medications in the past four weeks
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Colony growth rate of Pseudomonas aeruginosa in sputum of patients. Timepoint: Before the intervention begins and after the intervention ends. Method of measurement: Pseudomonas colony count by throat culture.;The Forced Expiratory Volume in 1 second. Timepoint: Before the intervention begins and after the intervention ends. Method of measurement: Spirometry.;The total forced vital capacity. Timepoint: Before the intervention begins and after the intervention ends. Method of measurement: Spirometry.;Body mass index. Timepoint: Before the intervention begins and after the intervention ends. Method of measurement: Meters and scales. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFaezeh Samadi
Mashhad University of Medical Sciences
Outcome results
None listed